Pharm aspects of immunology 2 Flashcards
What are some therapies for rheumatoid arthritis
anti-inflam drugs for symptom relief
- non-steroidal, NSAIDs
- Steroidal, glucocorticoids
DMARDS
slow the clinical progression of RA
- synthetic DMARDS, hydroxychloroquine
- targeted synthetic DMARDs, JAK inhibitors e.g. tofacitinib & baricitinib
biological agents
- TNF-blockers
outline Methotrexate (synthetic DMARD)
increases adenosine level- anti inflam
induces apoptosis of activated CD4+ & CD8+ T-Cells
antimetabolite (folate analogue), Inhibit cell proliferation
must be taken with folic acid supplements to reduce side effects caused by folic acid depletion
What are the side effects of synthetic DMARDS
30% exp side effects
- nausea, LOA, diarrhoea, headache, hair loss, hepato/nephrotoxicity
Outline the use of targeted synthetic DMARDs and name 2
patients with mod-sev RA who have had a minor response to DMARD may use tsDMARDs
tofacitinib- selectively inhibits JAK1 & JAK3
baricitinib- selectively inhibits JAK1 & JAK2
Outline the role of TNF in RA
TNF- secreted by macrophages, has a direct effect on endothelial cells, synovial fibroblasts and monocytes to release cytokines such as IL1 and IL8 which work to induce cartilage degradation
Name 4 licensed biologics for the treatment of RA
tnf-blockers- infliximab
monoclonal antibody against b-cells- rituximab
T-cell co stim inhibitor- abatacept
monoclonal antibody against IL-6R- sarilumab
Name the TNF-blockers
infliximab- partially humanized mouse monoclonal anti-hTNF alpha antibody
etanercept -soluble TNF receptor dimer
adalimumab- human IgG1 anti-TNF-alpha antibody
golimumab-human IgG1 anti-TNF-alpha antibody
certolizumab pegol- PEGylated anti-TNF-alpha monoclonal antibody fragment
Describe the structure of Infliximab and how it works
constant region of the antibody is human but the variable region is mouse derived
neutralizes free, membrane and receptor bound TNF-a
also used in treatment for crohns, uc, psoriasis
Describe how etanercept works
binds free and membrane bound TNF, reducing the accessible TNF in RA
outline the use of adalimumab and golimumab
both are fully human anti-TNF-alpha mABs
golimumab is used with MTX and has a longer half-life than adalimumab
outline the structure and use of certolizumab pegol
PEGylated anti-TNF-alpha monoclonal antibody fragment
PEG- when covalently attached to drugs, it reduces antigenicity/ immunogenicity, prolongs the circulatory time of the drugs
What are some consideration and side effects of anti-TNF therapy
patients must be screened for past history of TB, MS, recurrent inf, leg ulcers and past history of cancer.
may reactivate latent TB
How does rituximab work
rituximab opsonizes B-cells and are killed by 3 mechs:
- complement mediated cytotoxicity
- ADCC or CR mediated opsonic phagocytosis
- apoptosis
also used in treatment for SLE
How does abatacept work
- competitive inhibitor for CD28
- increases the threshold for T-cell activation and suppresses the proliferation of synovial recirculating T cells
- reduces the level of inflam mediators
What are the side effects of biological therapies
Increased risk of INF: upper resp tract, pneumonia, UTI’s
nausea, headache, HTN, allergic reactions